Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14699491 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: combination of lamivudine+adefovir vs entecavir

Indicates status has not been verified in more than two years